{"id":20696,"date":"2026-10-07T09:55:20","date_gmt":"2026-10-07T07:55:20","guid":{"rendered":"https:\/\/www.aglatech14.com\/?p=20696"},"modified":"2026-10-07T09:55:20","modified_gmt":"2026-10-07T07:55:20","slug":"informed-consent-translation-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/","title":{"rendered":"Translation of informed consent in clinical trials"},"content":{"rendered":"

Every Informed Consent Form (ICF)<\/strong>, the form through which participants in a clinical study are informed and provide their consent, has a dual purpose. On the one hand, it must meet the requirements of Ethics Committees and regulatory authorities, which are accustomed to rigorous medical and legal language. On the other, it must speak to patients, often without a scientific background, who need to genuinely understand what they are agreeing to.<\/p>\n

This tension is not a stylistic detail but lies at the heart of regulatory compliance. EU Regulation 536\/2014<\/strong> on clinical trials requires information to be provided in language that is clear, understandable and appropriate to the participant\u2019s level of cultural understanding. The ICH-GCP guidelines reinforce the same principle: consent is valid only when it is genuinely informed, not merely formally signed.<\/p>\n

For a CRO or sponsor operating across multiple countries, this means one thing: translating the ICF is not an administrative step. It is an integral part of the trial\u2019s regulatory strategy, just like the clinical protocol itself. Treating it as a secondary task and leaving it until the last minute exposes the study to avoidable risks from the earliest stages of submission.<\/p>\n

Critical challenges in ICF translation<\/h3>\n

Medical accuracy and Plain Language<\/strong><\/p>\n

The first balance to strike concerns linguistic register. An ICF translated in overly technical language may be incomprehensible to the average patient. An oversimplified version may lose clinically relevant nuances, with potential legal consequences. Certified medical translation must therefore apply the principles of Plain Language<\/strong>, using simple, direct writing that can also be understood by people without a medical background, without sacrificing the scientific accuracy required by the Ethics Committee.<\/p>\n

The linguistic validation process<\/strong><\/p>\n

To ensure semantic and cultural equivalence, many specialised language service providers (LSPs) apply a structured, multi-stage process inspired by best practices for the linguistic validation of clinical questionnaires.<\/p>\n

The Forward Translation<\/strong> produces an initial version in the target language. The source text is translated by a native-speaking linguist specialised in the medical field, with close attention to terminology, register and readability. In some cases, two translators work in parallel and their respective choices are then compared.<\/p>\n

The Back Translation<\/strong>, carried out by an independent translator, renders the text back into the source language to verify its fidelity. The translator works without seeing the original text: comparing the back-translated version with the original highlights omissions, additions and passages where the meaning has shifted.<\/p>\n

This is followed by Reconciliation<\/strong>, during which any discrepancies are resolved by an expert reviewer. The reviewer compares the original, the translation and the back translation, consults the translators involved and establishes the final wording, documenting the decisions made. This written audit trail can also be useful in the event of an inspection.<\/p>\n

In many cases, particularly for questionnaires and patient-facing materials, Cognitive Debriefing<\/strong> is also added: testing with a small group of representative participants to verify that the text is genuinely understandable in practice, not just on paper.<\/p>\n

Cultural sensitivity in delicate topics<\/strong><\/p>\n

Topics such as end-of-life issues, experimental risks or the use of biological data require careful cultural adaptation. Expressions that are neutral in one language may sound abrupt or be misunderstood in another. A linguist who is unfamiliar with the local sociocultural context risks creating anxiety, mistrust or misunderstanding, compromising the quality of the consent itself.\u00a0<\/strong><\/p>\n

The risks of an inaccurate translation<\/h3>\n

The consequences of a poorly translated ICF are not merely linguistic. They are operational, legal and reputational.\u00a0An Ethics Committee that identifies ambiguities or errors may reject the documentation, delaying the start of the study. Every week of delay has a direct cost in terms of budget and the trial\u2019s competitiveness compared with other sites.<\/p>\n

Even more serious is the risk that the consent itself may be deemed invalid. If a patient can demonstrate that they did not truly understand what they were signing, the entire enrolment process may be called into question, with repercussions for the integrity of the data collected.<\/p>\n

Finally, there is the risk of regulatory non-compliance. Authorities, including the EMA and FDA, regard the linguistic quality of consent documents as a substantive rather than merely formal element of a study\u2019s ethical assessment. The ICH E6(R2) Good Clinical Practice guidelines, available on the official ICH website<\/a>, are explicit on this point: protecting participants\u2019 rights also depends on the comprehensibility of the information provided. In the event of a regulatory inspection, the traceability of the translation and validation process often becomes a key element of the documentary review.<\/p>\n

The role of a specialised language service provider<\/h3>\n

Given this complexity, relying on a generalist translation provider is a risky choice. The Life Sciences sector requires specific expertise that can be verified through recognised certifications.<\/p>\n

The ISO 17100:2015<\/strong> standard defines requirements for professional translation processes, including multi-level quality control, from linguist selection to independent revision. ISO 18587:2017<\/strong> is equally relevant, as it governs the post-editing of content translated using machine translation technologies: it ensures that, even when technology is part of the process, qualified human oversight remains the final safeguard for quality. A structured provider demonstrates compliance with these standards as objective evidence of process quality.<\/p>\n

The team is equally important. Linguists involved in translating an ICF should be native speakers, specialised in the medical and legal fields, with direct experience in linguistic validation and Cognitive Debriefing. Knowledge of clinical terminology alone is not enough: they must understand the regulatory implications of every terminological choice.<\/p>\n

There is also one often underestimated aspect: managing local layout and formatting. Text length, page layout, special characters and even date formats can vary from country to country, and each version must remain consistent with the original approved by the Ethics Committee. For further information on the European regulatory framework for clinical trials, the European Commission provides up-to-date resources on its Public Health portal<\/a>.<\/p>\n

The linguistic component as part of the regulatory strategy<\/h3>\n

A well-translated ICF is not an ancillary trial cost. It is an investment in the quality of consent, the robustness of the data and patients\u2019 trust in scientific research.<\/p>\n

For CROs, sponsors and Ethics Committees, the question is not whether a professional ICF translation is needed, but whether their current language partner can manage all the stages described in this article with a structured and traceable approach.<\/p>\n

Integrating the linguistic component from the regulatory planning stage, rather than treating it as a downstream activity, can make the difference between smooth enrolment and weeks of avoidable delay. Involving the language partner as early as the protocol stage, rather than only once the documentation is ready, makes it possible to anticipate cultural and regulatory issues before they become concrete obstacles. It is worth assessing this before it becomes a problem.<\/p>\n

 <\/p>\n

Aglatech14 ContenTalkers<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Every Informed Consent Form (ICF), the form through which participants in a clinical study are informed and provide their consent, has a dual purpose. On the one hand, it must meet the requirements of Ethics Committees and regulatory authorities, which are accustomed to rigorous medical and legal language. On the other, it must speak to […]<\/p>\n","protected":false},"author":4,"featured_media":20695,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[71,1,77],"tags":[],"class_list":["post-20696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-legal-translations","category-scientific-medical-translations"],"yoast_head":"\nInformed consent translation: a guide to multinational trials<\/title>\n<meta name=\"description\" content=\"Translation of informed consent in clinical trials: regulatory requirements, linguistic validation and how to choose the right partner.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Informed consent translation: a guide to multinational trials\" \/>\n<meta property=\"og:description\" content=\"Translation of informed consent in clinical trials: regulatory requirements, linguistic validation and how to choose the right partner.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Aglatech14\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Aglatech14TraduzioniProfessionali\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-07T07:55:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/10\/Consenso-informato-multilingue-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"llegnani\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"llegnani\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/\"},\"author\":{\"name\":\"llegnani\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#\\\/schema\\\/person\\\/8ea60121c5c4bb9c4345aa90c86ef1dd\"},\"headline\":\"Translation of informed consent in clinical trials\",\"datePublished\":\"2026-10-07T07:55:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/\"},\"wordCount\":1123,\"publisher\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Consenso-informato-multilingue-scaled.jpg\",\"articleSection\":[\"Articles\",\"Legal translations\",\"Scientific medical translations\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/\",\"name\":\"Informed consent translation: a guide to multinational trials\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Consenso-informato-multilingue-scaled.jpg\",\"datePublished\":\"2026-10-07T07:55:20+00:00\",\"description\":\"Translation of informed consent in clinical trials: regulatory requirements, linguistic validation and how to choose the right partner.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Consenso-informato-multilingue-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Consenso-informato-multilingue-scaled.jpg\",\"width\":2560,\"height\":1709,\"caption\":\"Consenso informato multilingue\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/informed-consent-translation-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Translation of informed consent in clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/\",\"name\":\"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali\",\"description\":\"Societ\u00e0 di traduzioni professionali e traduzioni tecniche\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#organization\",\"name\":\"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_aglatech14_agenzia_traduzioni_milano.png\",\"contentUrl\":\"https:\\\/\\\/www.aglatech14.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_aglatech14_agenzia_traduzioni_milano.png\",\"width\":1602,\"height\":1595,\"caption\":\"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Aglatech14TraduzioniProfessionali\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/aglatech14\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.aglatech14.com\\\/en\\\/#\\\/schema\\\/person\\\/8ea60121c5c4bb9c4345aa90c86ef1dd\",\"name\":\"llegnani\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g\",\"caption\":\"llegnani\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Informed consent translation: a guide to multinational trials","description":"Translation of informed consent in clinical trials: regulatory requirements, linguistic validation and how to choose the right partner.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"Informed consent translation: a guide to multinational trials","og_description":"Translation of informed consent in clinical trials: regulatory requirements, linguistic validation and how to choose the right partner.","og_url":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/","og_site_name":"Aglatech14","article_publisher":"https:\/\/www.facebook.com\/Aglatech14TraduzioniProfessionali","article_published_time":"2026-10-07T07:55:20+00:00","og_image":[{"width":2560,"height":1709,"url":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/10\/Consenso-informato-multilingue-scaled.jpg","type":"image\/jpeg"}],"author":"llegnani","twitter_card":"summary_large_image","twitter_misc":{"Written by":"llegnani","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/"},"author":{"name":"llegnani","@id":"https:\/\/www.aglatech14.com\/en\/#\/schema\/person\/8ea60121c5c4bb9c4345aa90c86ef1dd"},"headline":"Translation of informed consent in clinical trials","datePublished":"2026-10-07T07:55:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/"},"wordCount":1123,"publisher":{"@id":"https:\/\/www.aglatech14.com\/en\/#organization"},"image":{"@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/10\/Consenso-informato-multilingue-scaled.jpg","articleSection":["Articles","Legal translations","Scientific medical translations"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/","url":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/","name":"Informed consent translation: a guide to multinational trials","isPartOf":{"@id":"https:\/\/www.aglatech14.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/10\/Consenso-informato-multilingue-scaled.jpg","datePublished":"2026-10-07T07:55:20+00:00","description":"Translation of informed consent in clinical trials: regulatory requirements, linguistic validation and how to choose the right partner.","breadcrumb":{"@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/#primaryimage","url":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/10\/Consenso-informato-multilingue-scaled.jpg","contentUrl":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2026\/10\/Consenso-informato-multilingue-scaled.jpg","width":2560,"height":1709,"caption":"Consenso informato multilingue"},{"@type":"BreadcrumbList","@id":"https:\/\/www.aglatech14.com\/en\/informed-consent-translation-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aglatech14.com\/en\/"},{"@type":"ListItem","position":2,"name":"Translation of informed consent in clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/www.aglatech14.com\/en\/#website","url":"https:\/\/www.aglatech14.com\/en\/","name":"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali","description":"Societ\u00e0 di traduzioni professionali e traduzioni tecniche","publisher":{"@id":"https:\/\/www.aglatech14.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aglatech14.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.aglatech14.com\/en\/#organization","name":"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali","url":"https:\/\/www.aglatech14.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.aglatech14.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2025\/03\/logo_aglatech14_agenzia_traduzioni_milano.png","contentUrl":"https:\/\/www.aglatech14.com\/wp-content\/uploads\/2025\/03\/logo_aglatech14_agenzia_traduzioni_milano.png","width":1602,"height":1595,"caption":"Aglatech 14 | Consulenti Linguistici e Traduzioni Professionali"},"image":{"@id":"https:\/\/www.aglatech14.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Aglatech14TraduzioniProfessionali","https:\/\/www.linkedin.com\/company\/aglatech14\/"]},{"@type":"Person","@id":"https:\/\/www.aglatech14.com\/en\/#\/schema\/person\/8ea60121c5c4bb9c4345aa90c86ef1dd","name":"llegnani","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f3914fc56a2d522d5151ad6a0a1dd086235d9bbc595fdfa7407f9013bfd6c74?s=96&d=mm&r=g","caption":"llegnani"}}]}},"_links":{"self":[{"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/posts\/20696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/comments?post=20696"}],"version-history":[{"count":1,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/posts\/20696\/revisions"}],"predecessor-version":[{"id":20697,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/posts\/20696\/revisions\/20697"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/media\/20695"}],"wp:attachment":[{"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/media?parent=20696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/categories?post=20696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aglatech14.com\/en\/wp-json\/wp\/v2\/tags?post=20696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}